department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

TerSera Therapeutics LLC · pharmadog

PUBLIC COMPANY

TerSera Therapeutics LLC

updated 1mo ago

community read0 votes

pipeline

5

marketed

3

phase 3

0

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(5)

pipeline depth5 products

1Phase 23Marketed1Unknown

Metrorrhagia (Abnormal Uterine Bleeding)

rolapitant hydrochloride

Chemotherapy Induced Nausea and Vomiting

telotristat ethyl

Carcinoid Syndrome (Malignant Carcinoid Syndrome)

Receptor tyrosine-protein kinase erbB-2

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 initiation (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view TerSera Therapeutics LLC jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Oncology3 Prostate Cancer1 Women's Health1

mentioned in

0news items

entity-linker matched

phase 1 initiation

TerSera Therapeutics LLC — goserelin LA (Phase I Trial Initiation)

Data sources

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase1A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancernot yet recruitingn=88
—Margetuximab Expanded Access Programapproved for marketing
—Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELOcompletedn=223
phase2Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydraminecompletedn=34

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagOncology5 co-mentions · 1 sources
tagBreast Cancer4 co-mentions · 1 sources
tagHER21 co-mentions · 1 sources
druggoserelin LA1 co-mentions · 1 sources
drugZOLADEX1 co-mentions · 1 sources